Khursheed Anwer

2.4k total citations
53 papers, 1.9k citations indexed

About

Khursheed Anwer is a scholar working on Molecular Biology, Genetics and Reproductive Medicine. According to data from OpenAlex, Khursheed Anwer has authored 53 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Genetics and 10 papers in Reproductive Medicine. Recurrent topics in Khursheed Anwer's work include RNA Interference and Gene Delivery (16 papers), Virus-based gene therapy research (15 papers) and Ovarian cancer diagnosis and treatment (10 papers). Khursheed Anwer is often cited by papers focused on RNA Interference and Gene Delivery (16 papers), Virus-based gene therapy research (15 papers) and Ovarian cancer diagnosis and treatment (10 papers). Khursheed Anwer collaborates with scholars based in United States, United Kingdom and France. Khursheed Anwer's co-authors include Barbara M. Sanborn, Alain Rolland, Jason G. Fewell, Russell J. Mumper, Enrico Stefani, C Oberti, L. Toro, Hiroaki Nitta, Seán M. Sullivan and Danny Lewis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Khursheed Anwer

51 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khursheed Anwer United States 27 1.2k 482 357 283 182 53 1.9k
Joel G. Turner United States 27 1.5k 1.2× 264 0.5× 463 1.3× 237 0.8× 109 0.6× 75 3.3k
Amandine Hurbin France 25 1.1k 0.9× 180 0.4× 156 0.4× 173 0.6× 236 1.3× 44 1.9k
Teppei Goto Japan 22 950 0.8× 398 0.8× 169 0.5× 73 0.3× 70 0.4× 52 1.9k
Shuren Zhang China 20 554 0.5× 209 0.4× 453 1.3× 65 0.2× 140 0.8× 52 1.9k
Mark R. Morgan United Kingdom 23 949 0.8× 167 0.3× 150 0.4× 43 0.2× 247 1.4× 42 2.2k
Zhen‐Ao Zhao China 25 1.7k 1.4× 226 0.5× 409 1.1× 28 0.1× 128 0.7× 58 2.6k
Todd C. Pappas United States 16 508 0.4× 509 1.1× 330 0.9× 20 0.1× 281 1.5× 39 2.0k
Elena Boggio Italy 27 717 0.6× 469 1.0× 424 1.2× 19 0.1× 225 1.2× 64 2.0k
Theresa V. Strong United States 35 1.7k 1.4× 1.1k 2.3× 408 1.1× 32 0.1× 359 2.0× 84 4.0k
Catherine Moreau France 24 863 0.7× 110 0.2× 264 0.7× 30 0.1× 44 0.2× 35 1.8k

Countries citing papers authored by Khursheed Anwer

Since Specialization
Citations

This map shows the geographic impact of Khursheed Anwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khursheed Anwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khursheed Anwer more than expected).

Fields of papers citing papers by Khursheed Anwer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khursheed Anwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khursheed Anwer. The network helps show where Khursheed Anwer may publish in the future.

Co-authorship network of co-authors of Khursheed Anwer

This figure shows the co-authorship network connecting the top 25 collaborators of Khursheed Anwer. A scholar is included among the top collaborators of Khursheed Anwer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khursheed Anwer. Khursheed Anwer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sood, Subeena, Majed Matar, Kempaiah Rayavara, et al.. (2024). Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymer. Vaccine. 42(6). 1300–1310.
2.
Yin, Xiang, Elizabeth B. Lamont, Premal H. Thaker, et al.. (2023). Historic Clinical Trial External Control Arm Provides Actionable GEN-1 Efficacy Estimate Before a Randomized Trial. JCO Clinical Cancer Informatics. 7(7). e2200103–e2200103. 7 indexed citations
3.
Thaker, Premal H., William H. Bradley, Charles A. Leath, et al.. (2021). GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study. Clinical Cancer Research. 27(20). 5536–5545. 19 indexed citations
4.
5.
Negm, Nabel A., et al.. (2016). Synthesis, Characterization and Biological Activity of Some Pyrazole-Pyrazolone Derivatives. Egyptian Journal of Chemistry. 59(4). 663–672. 11 indexed citations
6.
Anwer, Khursheed, FJ Kelly, Christina Chu, et al.. (2013). Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer. Gynecologic Oncology. 131(1). 169–173. 47 indexed citations
7.
Matar, Majed, et al.. (2011). Versatile cationic lipids for siRNA delivery. Journal of Controlled Release. 158(2). 269–276. 34 indexed citations
8.
Polach, Kevin J., Majed Matar, Angela Rea-Ramsey, et al.. (2011). Delivery of siRNA to the Mouse Lung via a Functionalized Lipopolyamine. Molecular Therapy. 20(1). 91–100. 37 indexed citations
9.
Fewell, Jason G., et al.. (2009). Treatment of disseminated ovarian cancer using nonviral interleukin‐12 gene therapy delivered intraperitoneally. The Journal of Gene Medicine. 11(8). 718–728. 42 indexed citations
10.
Anwer, Khursheed, Mack N. Barnes, Jason G. Fewell, Danny Lewis, & Ronald D. Alvarez. (2009). Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer. Gene Therapy. 17(3). 360–369. 79 indexed citations
11.
Szymanski, Paul, Khursheed Anwer, & Seán M. Sullivan. (2006). Development and characterization of a synthetic promoter for selective expression in proliferating endothelial cells. The Journal of Gene Medicine. 8(4). 514–523. 9 indexed citations
12.
Fewell, Jason G., et al.. (2005). Synthesis and application of a non-viral gene delivery system for immunogene therapy of cancer. Journal of Controlled Release. 109(1-3). 288–298. 45 indexed citations
13.
Anwer, Khursheed, et al.. (2003). Recent Progress in Polymeric Gene Delivery Systems. Critical Reviews in Therapeutic Drug Carrier Systems. 20(4). 249–293. 49 indexed citations
14.
Anwer, Khursheed, et al.. (2000). Optimization of Cationic Lipid/DNA Complexes for Systemic Gene Transfer to Tumor Lesions. Journal of drug targeting. 8(2). 125–135. 30 indexed citations
15.
Anwer, Khursheed, Mark Logan, Manpreet S. Wadhwa, et al.. (2000). Synthetic Glycopeptide-Based Delivery Systems for Systemic Gene Targeting to Hepatocytes. Pharmaceutical Research. 17(4). 451–459. 10 indexed citations
16.
Anwer, Khursheed, Mei Shi, Jijun Wang, et al.. (1999). Synergistic Effect of Formulated Plasmid and Needle-Free Injection for Genetic Vaccines. Pharmaceutical Research. 16(6). 889–895. 35 indexed citations
17.
Mahato, Ram I., Khursheed Anwer, Clare Meaney, et al.. (1998). Biodistribution and Gene Expression of Lipid/Plasmid Complexes after Systemic Administration. Human Gene Therapy. 9(14). 2083–2099. 131 indexed citations
18.
Wang, Jijun, et al.. (1998). Protective interactive noncondensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle. Journal of Controlled Release. 52(1-2). 191–203. 100 indexed citations
19.
Alila, Hector W., Michael M. Coleman, Hiroaki Nitta, et al.. (1997). Expression of Biologically Active Human Insulin-like Growth Factor-I Following Intramuscular Injection of a Formulated Plasmid in Rats. Human Gene Therapy. 8(15). 1785–1795. 51 indexed citations
20.
Sanborn, Barbara M., et al.. (1995). Mechanisms regulating oxytocin receptor coupling to phospholipase C in rat and human myometrium.. PubMed. 395. 469–79. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joel G. Turner Breakdown of academic impact, for papers by Amandine Hurbin Breakdown of academic impact, for papers by Teppei Goto Breakdown of academic impact, for papers by Shuren Zhang Breakdown of academic impact, for papers by Mark R. Morgan Breakdown of academic impact, for papers by Zhen‐Ao Zhao Breakdown of academic impact, for papers by Todd C. Pappas Breakdown of academic impact, for papers by Elena Boggio Breakdown of academic impact, for papers by Theresa V. Strong Breakdown of academic impact, for papers by Catherine Moreau
Rankless by CCL
2026